nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—EGF—endothelium—Behcet's disease	0.0287	0.0887	CbGeAlD
Sucralfate—FGB—Beta2 integrin cell surface interactions—ITGB2—Behcet's disease	0.0274	0.0405	CbGpPWpGaD
Sucralfate—FGG—Beta2 integrin cell surface interactions—ITGB2—Behcet's disease	0.0268	0.0397	CbGpPWpGaD
Sucralfate—FGA—Beta2 integrin cell surface interactions—ITGB2—Behcet's disease	0.0268	0.0397	CbGpPWpGaD
Sucralfate—EGF—blood vessel—Behcet's disease	0.0265	0.0818	CbGeAlD
Sucralfate—FGB—Beta2 integrin cell surface interactions—ITGAL—Behcet's disease	0.0247	0.0366	CbGpPWpGaD
Sucralfate—FGA—Beta2 integrin cell surface interactions—ITGAL—Behcet's disease	0.0242	0.0358	CbGpPWpGaD
Sucralfate—FGG—Beta2 integrin cell surface interactions—ITGAL—Behcet's disease	0.0242	0.0358	CbGpPWpGaD
Sucralfate—EGF—mouth—Behcet's disease	0.0222	0.0684	CbGeAlD
Sucralfate—FGB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGB2—Behcet's disease	0.0204	0.0301	CbGpPWpGaD
Sucralfate—FGA—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGB2—Behcet's disease	0.02	0.0295	CbGpPWpGaD
Sucralfate—FGG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGB2—Behcet's disease	0.02	0.0295	CbGpPWpGaD
Sucralfate—FGA—brainstem—Behcet's disease	0.0198	0.0612	CbGeAlD
Sucralfate—PGA5—nervous system—Behcet's disease	0.0179	0.0551	CbGeAlD
Sucralfate—PGA5—central nervous system—Behcet's disease	0.0172	0.0531	CbGeAlD
Sucralfate—EGF—brainstem—Behcet's disease	0.0145	0.0447	CbGeAlD
Sucralfate—FGB—Integrin cell surface interactions—ITGB2—Behcet's disease	0.0142	0.021	CbGpPWpGaD
Sucralfate—EGF—eye—Behcet's disease	0.0141	0.0435	CbGeAlD
Sucralfate—EGF—retina—Behcet's disease	0.014	0.0431	CbGeAlD
Sucralfate—FGA—Integrin cell surface interactions—ITGB2—Behcet's disease	0.0139	0.0206	CbGpPWpGaD
Sucralfate—FGG—Integrin cell surface interactions—ITGB2—Behcet's disease	0.0139	0.0206	CbGpPWpGaD
Sucralfate—PGA5—brain—Behcet's disease	0.0137	0.0421	CbGeAlD
Sucralfate—FGB—Integrin cell surface interactions—ITGAL—Behcet's disease	0.0128	0.0189	CbGpPWpGaD
Sucralfate—FGA—Integrin cell surface interactions—ITGAL—Behcet's disease	0.0125	0.0186	CbGpPWpGaD
Sucralfate—FGG—Integrin cell surface interactions—ITGAL—Behcet's disease	0.0125	0.0186	CbGpPWpGaD
Sucralfate—FGF2—eye—Behcet's disease	0.0124	0.0384	CbGeAlD
Sucralfate—EGF—skin of body—Behcet's disease	0.0123	0.0379	CbGeAlD
Sucralfate—EGF—cardiac atrium—Behcet's disease	0.0107	0.0331	CbGeAlD
Sucralfate—FGB—Blood Clotting Cascade—SERPINE1—Behcet's disease	0.0107	0.0158	CbGpPWpGaD
Sucralfate—FGA—Blood Clotting Cascade—SERPINE1—Behcet's disease	0.0104	0.0154	CbGpPWpGaD
Sucralfate—FGG—Blood Clotting Cascade—SERPINE1—Behcet's disease	0.0104	0.0154	CbGpPWpGaD
Sucralfate—FGA—nervous system—Behcet's disease	0.0104	0.0321	CbGeAlD
Sucralfate—FGB—Beta2 integrin cell surface interactions—ICAM1—Behcet's disease	0.0102	0.0151	CbGpPWpGaD
Sucralfate—FGA—Beta2 integrin cell surface interactions—ICAM1—Behcet's disease	0.01	0.0148	CbGpPWpGaD
Sucralfate—FGG—Beta2 integrin cell surface interactions—ICAM1—Behcet's disease	0.01	0.0148	CbGpPWpGaD
Sucralfate—FGA—central nervous system—Behcet's disease	0.01	0.0309	CbGeAlD
Sucralfate—FGF2—mammalian vulva—Behcet's disease	0.00987	0.0305	CbGeAlD
Sucralfate—EGF—spinal cord—Behcet's disease	0.00901	0.0278	CbGeAlD
Sucralfate—FGF2—medulla oblongata—Behcet's disease	0.00891	0.0275	CbGeAlD
Sucralfate—FGF2—midbrain—Behcet's disease	0.00815	0.0251	CbGeAlD
Sucralfate—FGF2—spinal cord—Behcet's disease	0.00795	0.0245	CbGeAlD
Sucralfate—FGA—brain—Behcet's disease	0.00795	0.0245	CbGeAlD
Sucralfate—EGF—nervous system—Behcet's disease	0.00759	0.0234	CbGeAlD
Sucralfate—EGF—central nervous system—Behcet's disease	0.00731	0.0226	CbGeAlD
Sucralfate—FGB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—Behcet's disease	0.00635	0.00939	CbGpPWpGaD
Sucralfate—FGG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—Behcet's disease	0.00622	0.0092	CbGpPWpGaD
Sucralfate—FGA—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—Behcet's disease	0.00622	0.0092	CbGpPWpGaD
Sucralfate—EGF—brain—Behcet's disease	0.0058	0.0179	CbGeAlD
Sucralfate—FGB—Integrin cell surface interactions—ICAM1—Behcet's disease	0.00529	0.00783	CbGpPWpGaD
Sucralfate—FGG—Integrin cell surface interactions—ICAM1—Behcet's disease	0.00519	0.00767	CbGpPWpGaD
Sucralfate—FGA—Integrin cell surface interactions—ICAM1—Behcet's disease	0.00519	0.00767	CbGpPWpGaD
Sucralfate—FGF2—brain—Behcet's disease	0.00512	0.0158	CbGeAlD
Sucralfate—FGB—Complement and Coagulation Cascades—SERPINE1—Behcet's disease	0.00484	0.00716	CbGpPWpGaD
Sucralfate—FGB—Platelet degranulation—APOA1—Behcet's disease	0.00478	0.00707	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—ITGB2—Behcet's disease	0.00468	0.00693	CbGpPWpGaD
Sucralfate—FGA—Platelet degranulation—APOA1—Behcet's disease	0.00468	0.00692	CbGpPWpGaD
Sucralfate—FGA—Amyloids—APOA1—Behcet's disease	0.00468	0.00692	CbGpPWpGaD
Sucralfate—FGG—Platelet degranulation—APOA1—Behcet's disease	0.00468	0.00692	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—ITGB2—Behcet's disease	0.00459	0.00679	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—ITGB2—Behcet's disease	0.00459	0.00679	CbGpPWpGaD
Sucralfate—FGB—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.00455	0.00673	CbGpPWpGaD
Sucralfate—FGA—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.00446	0.0066	CbGpPWpGaD
Sucralfate—FGG—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.00446	0.0066	CbGpPWpGaD
Sucralfate—FGG—Glucocorticoid receptor regulatory network—ICAM1—Behcet's disease	0.00436	0.00645	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—ITGAL—Behcet's disease	0.00422	0.00625	CbGpPWpGaD
Sucralfate—EGF—Bladder Cancer—CXCL8—Behcet's disease	0.00419	0.0062	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—ITGAL—Behcet's disease	0.00414	0.00612	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—ITGAL—Behcet's disease	0.00414	0.00612	CbGpPWpGaD
Sucralfate—FGB—Platelet degranulation—SERPINE1—Behcet's disease	0.00379	0.00561	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—ITGB2—Behcet's disease	0.00372	0.00551	CbGpPWpGaD
Sucralfate—FGG—Platelet degranulation—SERPINE1—Behcet's disease	0.00371	0.0055	CbGpPWpGaD
Sucralfate—FGA—Platelet degranulation—SERPINE1—Behcet's disease	0.00371	0.0055	CbGpPWpGaD
Sucralfate—EGF—Thromboxane A2 receptor signaling—ICAM1—Behcet's disease	0.00369	0.00546	CbGpPWpGaD
Sucralfate—FGF2—Angiogenesis—NOS3—Behcet's disease	0.00367	0.00543	CbGpPWpGaD
Sucralfate—FGB—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00361	0.00534	CbGpPWpGaD
Sucralfate—FGA—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00354	0.00524	CbGpPWpGaD
Sucralfate—FGG—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00354	0.00524	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—ITGAL—Behcet's disease	0.00336	0.00497	CbGpPWpGaD
Sucralfate—EGF—TGF-beta Receptor Signaling—SERPINE1—Behcet's disease	0.00318	0.0047	CbGpPWpGaD
Sucralfate—FGG—Glucocorticoid receptor regulatory network—CXCL8—Behcet's disease	0.00308	0.00456	CbGpPWpGaD
Sucralfate—EGF—Thromboxane A2 receptor signaling—NOS3—Behcet's disease	0.00294	0.00436	CbGpPWpGaD
Sucralfate—EGF—Platelet degranulation—APOA1—Behcet's disease	0.00292	0.00432	CbGpPWpGaD
Sucralfate—ALB—Scavenging of heme from plasma—APOA1—Behcet's disease	0.00288	0.00427	CbGpPWpGaD
Sucralfate—EGF—SHP2 signaling—NOS3—Behcet's disease	0.00286	0.00424	CbGpPWpGaD
Sucralfate—EGF—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.00278	0.00412	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—ITGB2—Behcet's disease	0.00278	0.00412	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—ITGB2—Behcet's disease	0.00273	0.00403	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—ITGB2—Behcet's disease	0.00273	0.00403	CbGpPWpGaD
Sucralfate—ALB—HDL-mediated lipid transport—APOA1—Behcet's disease	0.00257	0.00381	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—ITGAL—Behcet's disease	0.00251	0.00371	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—ITGAL—Behcet's disease	0.00246	0.00364	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—ITGAL—Behcet's disease	0.00246	0.00364	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—MEFV—Behcet's disease	0.00232	0.00344	CbGpPWpGaD
Sucralfate—EGF—Platelet degranulation—SERPINE1—Behcet's disease	0.00232	0.00343	CbGpPWpGaD
Sucralfate—EGF—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00221	0.00327	CbGpPWpGaD
Sucralfate—FGB—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00212	0.00313	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00208	0.00307	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00208	0.00307	CbGpPWpGaD
Sucralfate—EGF—Ceramide signaling pathway—TNF—Behcet's disease	0.00206	0.00304	CbGpPWpGaD
Sucralfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—NOS3—Behcet's disease	0.00204	0.00302	CbGpPWpGaD
Sucralfate—ALB—brain—Behcet's disease	0.00201	0.00619	CbGeAlD
Sucralfate—EGF—Adaptive Immune System—ERAP1—Behcet's disease	0.00199	0.00294	CbGpPWpGaD
Sucralfate—EGF—TGF-beta Receptor Signaling—TNF—Behcet's disease	0.00187	0.00277	CbGpPWpGaD
Sucralfate—ALB—Lipoprotein metabolism—APOB—Behcet's disease	0.00187	0.00276	CbGpPWpGaD
Sucralfate—EGF—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.00184	0.00273	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—ITGB2—Behcet's disease	0.00181	0.00268	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—HLA-B—Behcet's disease	0.00181	0.00268	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—ICAM1—Behcet's disease	0.00175	0.00258	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—ICAM1—Behcet's disease	0.00171	0.00253	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—ICAM1—Behcet's disease	0.00171	0.00253	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—ITGB2—Behcet's disease	0.0017	0.00252	CbGpPWpGaD
Sucralfate—FGB—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.00168	0.00249	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.00165	0.00244	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.00165	0.00244	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—ITGAL—Behcet's disease	0.00163	0.00242	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—ITGAL—Behcet's disease	0.00153	0.00227	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—ITGB2—Behcet's disease	0.00153	0.00227	CbGpPWpGaD
Sucralfate—ALB—Lipoprotein metabolism—APOA1—Behcet's disease	0.00148	0.00219	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ITGB2—Behcet's disease	0.00147	0.00218	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MEFV—Behcet's disease	0.00147	0.00217	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—SERPINE1—Behcet's disease	0.00146	0.00216	CbGpPWpGaD
Sucralfate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOB—Behcet's disease	0.00145	0.00215	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—SERPINE1—Behcet's disease	0.00143	0.00211	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—SERPINE1—Behcet's disease	0.00143	0.00211	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—APOB—Behcet's disease	0.00138	0.00204	CbGpPWpGaD
Sucralfate—EGF—Immune System—MEFV—Behcet's disease	0.00135	0.002	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—APOB—Behcet's disease	0.00135	0.002	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—APOB—Behcet's disease	0.00135	0.002	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ITGAL—Behcet's disease	0.00133	0.00196	CbGpPWpGaD
Sucralfate—EGF—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.00131	0.00194	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.0013	0.00192	CbGpPWpGaD
Sucralfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—TNF—Behcet's disease	0.00126	0.00186	CbGpPWpGaD
Sucralfate—EGF—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.00126	0.00186	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ERAP1—Behcet's disease	0.00126	0.00186	CbGpPWpGaD
Sucralfate—ALB—Lipid and lipoprotein metabolism—APOB—Behcet's disease	0.00124	0.00184	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—APOB—Behcet's disease	0.00122	0.00181	CbGpPWpGaD
Sucralfate—EGF—Immune System—ERAP1—Behcet's disease	0.00121	0.00178	CbGpPWpGaD
Sucralfate—FGF2—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.00117	0.00173	CbGpPWpGaD
Sucralfate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—Behcet's disease	0.00115	0.0017	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—HLA-B—Behcet's disease	0.00115	0.00169	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—APOA1—Behcet's disease	0.00109	0.00162	CbGpPWpGaD
Sucralfate—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—Behcet's disease	0.00109	0.00161	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—APOA1—Behcet's disease	0.00107	0.00158	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—APOA1—Behcet's disease	0.00107	0.00158	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.00103	0.00152	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—CAT—Behcet's disease	0.00102	0.00151	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—APOB—Behcet's disease	0.000994	0.00147	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCR1—Behcet's disease	0.000991	0.00147	CbGpPWpGaD
Sucralfate—ALB—Lipid and lipoprotein metabolism—APOA1—Behcet's disease	0.000982	0.00145	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCR1—Behcet's disease	0.000971	0.00144	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCR1—Behcet's disease	0.000971	0.00144	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ITGB2—Behcet's disease	0.000969	0.00143	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—APOA1—Behcet's disease	0.000966	0.00143	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ITGB2—Behcet's disease	0.000931	0.00138	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—ICAM1—Behcet's disease	0.000918	0.00136	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CTLA4—Behcet's disease	0.000913	0.00135	CbGpPWpGaD
Sucralfate—EGF—Immune System—ITGB2—Behcet's disease	0.000892	0.00132	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—SERPINE1—Behcet's disease	0.000867	0.00128	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MEFV—Behcet's disease	0.000856	0.00127	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—SERPINE1—Behcet's disease	0.000849	0.00126	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—SERPINE1—Behcet's disease	0.000849	0.00126	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—APOB—Behcet's disease	0.000844	0.00125	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ITGAL—Behcet's disease	0.000839	0.00124	CbGpPWpGaD
Sucralfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	0.000832	0.00123	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—NOS3—Behcet's disease	0.000828	0.00122	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—CAT—Behcet's disease	0.000813	0.0012	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—NOS3—Behcet's disease	0.000811	0.0012	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—NOS3—Behcet's disease	0.000811	0.0012	CbGpPWpGaD
Sucralfate—EGF—Immune System—ITGAL—Behcet's disease	0.000804	0.00119	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—APOB—Behcet's disease	0.000789	0.00117	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—APOA1—Behcet's disease	0.000786	0.00116	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—SERPINE1—Behcet's disease	0.000767	0.00113	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ERAP1—Behcet's disease	0.000763	0.00113	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TNF—Behcet's disease	0.000755	0.00112	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—ICAM1—Behcet's disease	0.000747	0.00111	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HLA-B—Behcet's disease	0.000703	0.00104	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000681	0.00101	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—ICAM1—Behcet's disease	0.000676	0.001	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HLA-B—Behcet's disease	0.000675	0.000999	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—APOA1—Behcet's disease	0.000674	0.000997	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—APOA1—Behcet's disease	0.000668	0.000988	CbGpPWpGaD
Sucralfate—FGA—Disease—APOB—Behcet's disease	0.000655	0.000969	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—Behcet's disease	0.000642	0.00095	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000624	0.000924	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—SERPINE1—Behcet's disease	0.000624	0.000923	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCR1—Behcet's disease	0.000606	0.000897	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000593	0.000878	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CTLA4—Behcet's disease	0.000578	0.000855	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—SERPINE1—Behcet's disease	0.000565	0.000835	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ITGB2—Behcet's disease	0.000564	0.000835	CbGpPWpGaD
Sucralfate—EGF—Immune System—CTLA4—Behcet's disease	0.000554	0.000819	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—ICAM1—Behcet's disease	0.000549	0.000812	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—SERPINE1—Behcet's disease	0.000535	0.000792	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—SERPINE1—Behcet's disease	0.00053	0.000784	CbGpPWpGaD
Sucralfate—FGA—Disease—APOA1—Behcet's disease	0.000518	0.000766	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—Behcet's disease	0.00051	0.000754	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ITGAL—Behcet's disease	0.000509	0.000753	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—NOS3—Behcet's disease	0.000506	0.000749	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000496	0.000733	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOB—Behcet's disease	0.000468	0.000692	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOB—Behcet's disease	0.000458	0.000678	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOB—Behcet's disease	0.000458	0.000678	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—Behcet's disease	0.000452	0.000669	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HLA-B—Behcet's disease	0.000445	0.000658	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000431	0.000638	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HLA-B—Behcet's disease	0.000427	0.000632	CbGpPWpGaD
Sucralfate—FGA—Disease—SERPINE1—Behcet's disease	0.000411	0.000608	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-B—Behcet's disease	0.000409	0.000606	CbGpPWpGaD
Sucralfate—EGF—Disease—APOB—Behcet's disease	0.000409	0.000605	CbGpPWpGaD
Sucralfate—FGA—Disease—NOS3—Behcet's disease	0.000393	0.000581	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ITGB2—Behcet's disease	0.000392	0.000581	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR1—Behcet's disease	0.000384	0.000568	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOA1—Behcet's disease	0.00037	0.000548	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—Behcet's disease	0.000368	0.000544	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOA1—Behcet's disease	0.000363	0.000537	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOA1—Behcet's disease	0.000363	0.000537	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—ITGAL—Behcet's disease	0.000354	0.000524	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CTLA4—Behcet's disease	0.00035	0.000518	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—ICAM1—Behcet's disease	0.000347	0.000514	CbGpPWpGaD
Sucralfate—EGF—Immune System—ICAM1—Behcet's disease	0.000333	0.000492	CbGpPWpGaD
Sucralfate—EGF—Disease—APOA1—Behcet's disease	0.000323	0.000478	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.000299	0.000442	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SERPINE1—Behcet's disease	0.000294	0.000435	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—Behcet's disease	0.000292	0.000432	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SERPINE1—Behcet's disease	0.000288	0.000426	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SERPINE1—Behcet's disease	0.000288	0.000426	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOB—Behcet's disease	0.000286	0.000423	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NOS3—Behcet's disease	0.000281	0.000415	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NOS3—Behcet's disease	0.000275	0.000407	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NOS3—Behcet's disease	0.000275	0.000407	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-B—Behcet's disease	0.000259	0.000383	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOB—Behcet's disease	0.000259	0.000383	CbGpPWpGaD
Sucralfate—EGF—Disease—SERPINE1—Behcet's disease	0.000257	0.00038	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCL8—Behcet's disease	0.000249	0.000368	CbGpPWpGaD
Sucralfate—EGF—Disease—NOS3—Behcet's disease	0.000245	0.000362	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCL8—Behcet's disease	0.000244	0.000361	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCL8—Behcet's disease	0.000244	0.000361	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000237	0.000351	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOA1—Behcet's disease	0.000226	0.000335	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ICAM1—Behcet's disease	0.000211	0.000312	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOA1—Behcet's disease	0.000205	0.000303	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—Behcet's disease	0.000202	0.000298	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—APOB—Behcet's disease	0.000195	0.000288	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOB—Behcet's disease	0.000181	0.000268	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SERPINE1—Behcet's disease	0.00018	0.000266	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000177	0.000262	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOS3—Behcet's disease	0.000172	0.000254	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000169	0.000249	CbGpPWpGaD
Sucralfate—FGF2—Disease—SERPINE1—Behcet's disease	0.000162	0.00024	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS3—Behcet's disease	0.000155	0.000229	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—APOA1—Behcet's disease	0.000154	0.000228	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL8—Behcet's disease	0.000152	0.000225	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOA1—Behcet's disease	0.000143	0.000212	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.00014	0.000208	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000133	0.000197	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SERPINE1—Behcet's disease	0.000122	0.000181	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS3—Behcet's disease	0.000117	0.000173	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SERPINE1—Behcet's disease	0.000114	0.000168	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOS3—Behcet's disease	0.000109	0.000161	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL8—Behcet's disease	9.63e-05	0.000143	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CAT—Behcet's disease	8.13e-05	0.00012	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOB—Behcet's disease	7.9e-05	0.000117	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOA1—Behcet's disease	6.25e-05	9.24e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NOS3—Behcet's disease	4.73e-05	7.01e-05	CbGpPWpGaD
